[
  {
    "ts": null,
    "headline": "Neurocrine Biosciences to Report Q4 Earnings: What's in the Cards?",
    "summary": "NBIX heads into fourth-quarter earnings with Ingrezza sales strength, growing Crenessity revenues and rising focus on late-stage pipeline updates.",
    "url": "https://finnhub.io/api/news?id=3423a31aed5e33810ee668b432c105ea65a484ad86a4f3786a1cb58b6047e3a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770301740,
      "headline": "Neurocrine Biosciences to Report Q4 Earnings: What's in the Cards?",
      "id": 138364823,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "NBIX heads into fourth-quarter earnings with Ingrezza sales strength, growing Crenessity revenues and rising focus on late-stage pipeline updates.",
      "url": "https://finnhub.io/api/news?id=3423a31aed5e33810ee668b432c105ea65a484ad86a4f3786a1cb58b6047e3a8"
    }
  }
]